CN Patent

CN110615744B — 一种布瓦西坦中间体及其制备方法

Assigned to Shanghai Puyi Chemical Technology Co Ltd · Expires 2023-01-06 · 3y expired

What this patent protects

本发明提出一种化合物,3‑((((S)‑1‑氨基‑1‑氧代丁‑2‑基)氨基)甲基)己酸(I),以及其制备方法。该化合物(I)包含(R)‑3‑((((S)‑1‑氨基‑1‑氧代丁‑2‑基)氨基)甲基)己酸(I)‑R,或(S)‑3‑((((S)‑1‑氨基‑1‑氧代丁‑2‑基)氨基)甲基)己酸(I)‑S,或者任意比例的(I)‑R与(I)‑S的混合物。本发明式(I)的化合物,可以用于布瓦西坦的合成,为设计简洁高效的路线合成布瓦西坦提供了新的思路和方法。

USPTO Abstract

本发明提出一种化合物,3‑((((S)‑1‑氨基‑1‑氧代丁‑2‑基)氨基)甲基)己酸(I),以及其制备方法。该化合物(I)包含(R)‑3‑((((S)‑1‑氨基‑1‑氧代丁‑2‑基)氨基)甲基)己酸(I)‑R,或(S)‑3‑((((S)‑1‑氨基‑1‑氧代丁‑2‑基)氨基)甲基)己酸(I)‑S,或者任意比例的(I)‑R与(I)‑S的混合物。本发明式(I)的化合物,可以用于布瓦西坦的合成,为设计简洁高效的路线合成布瓦西坦提供了新的思路和方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN110615744B
Jurisdiction
CN
Classification
Expires
2023-01-06
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Puyi Chemical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.